Sürmelioğlu, N. And Demirtürk, E. 2024. Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. . INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.105414204496 , 1-12.

Sürmelioğlu, N., & Demirtürk, E., (2024). Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. . INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.105414204496, 1-12.

Sürmelioğlu, NURSEL, And ESRA DEMİRTÜRK. "Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. ," INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.105414204496, 1-12, 2024

Sürmelioğlu, NURSEL And Demirtürk, ESRA. "Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. ." INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.105414204496, pp.1-12, 2024

Sürmelioğlu, N. And Demirtürk, E. (2024) . "Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. ." INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.105414204496, pp.1-12.

@article{article, author={NURSEL SÜRMELİOĞLU And author={ESRA DEMİRTÜRK}, title={Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use. }, journal={INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS}, year=2024, pages={1-12} }